Price $18.23 |
Market Cap
314.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.09
|
P/S
4.86
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.2K
|
FCF
-0.5
|
|
Op. Margin
-16.80%
|
Net Margin
-16.80%
|
ROE
-29.10%
|
ROI
-34.30%
|
|
ROA
-22.90%
|
EPS Growth
24.10%
|
Current Ratio
2.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc (ASRT) | $0.71 | - | - | 63.3M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $2.50 | - | 8.80% | 16.7M | Strong Buy |
| Biomerica, Inc. (BMRA) | $2.85 | - | - | 29.7M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.94 | - | - | 110.4M | Strong Buy |
| Quorum Health Corp (QHC) | $0.94 | - | - | 19M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
